Review
Sep 2026
Colchicine for cardiovascular secondary prevention: evidence from recent trials and meta-analyses.
Low-dose colchicine has established residual inflammation as an actionable target in secondary prevention of vascular events in patients with chronic coronary disease or recent myocardial infarction.
V. Muroke, Michelle Samuel, R. Pierre et al.
· Current Opinion in Cardiolog... · 0 citations